Načítá se...
Choosing Non-Vitamin K Antagonist Oral Anticoagulants: Practical Considerations We Need to Know
BACKGROUND: Warfarin is a well-established agent for use in the prevention of stroke or systemic embolic event (SEE) in patients with nonvalvular atrial fibrillation (NVAF) and for the treatment of venous thromboembolism (VTE). However, management of patients requiring oral anticoagulation with warf...
Uloženo v:
| Vydáno v: | Ochsner J |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
the Academic Division of Ochsner Clinic Foundation
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5158161/ https://ncbi.nlm.nih.gov/pubmed/27999513 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|